Trade Summary

3 days ago, Weiss Amir, serving as Chief Accounting Officer at Teva Pharmaceutical Industries Ltd (TEVA), sold 10,679 shares at $36.00 per share, for a total transaction value of $384,444.00. Following this transaction, Weiss Amir now holds 20,016 shares of TEVA.

This sale represents a 35.00% decrease in Weiss Amir's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, May 6, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 7, 2026, 1 day after the trade was made.

Teva Pharmaceutical Industries Ltd operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.